| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹34.02 Cr |
| Reserved for Market Maker | ₹1.71 Cr |
| Net Issue Size | ₹34.02 Cr |
| Fresh Issue | ₹32.31 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน59.00-63.00 per share |
| NSE Code | SHEEL |
| Registrar | Skyline Financial Services Pvt.Ltd. |
| Lead Managers | Narnolia Financial Services Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 4,000 shares ยท Multiples of 2,000 shares
Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.
The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming.
The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs.
They also deliver landscaping services to the government and private sectors.
The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety.
The company's Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.
Sheel Biotech offers a diverse range of services and products, including:
As of September 12, 2025, the Company has 160 permanent employees on its payroll.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Capital Expenditure Requirement | 9.12 |
| 2 | Working Capital Requirement | 15.88 |
| 3 | General Corporate Purposes | 4.77 |
| 4 | Issue Expense | 4.25 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 113.28 | 105.95 | 93.89 |
| Total Income | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.47 | 5.08 |
| EBITDA | 14.97 | 14.45 | 8.83 |
| NET Worth | 83.85 | 72.69 | 63.54 |
| Reserves and Surplus | 68.90 | 68.58 | 59.40 |
| Total Borrowing | 17.36 | 23.54 | 19.17 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt / Equity | 0.21% |
| RoNW | 13.59% |
| PAT Margin | 10.45% |
| EBITDA Margin | 14.71% |
| Price to Book Value | 1.11 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 7.11 | 5.23 |
| P/E (x) | 8.86 | 12.06 |
| Promoter Holding | 96.99% | 71.26% |
| Market Cap | โน128.22 Cr. | |